2026 Regular Session
HB870   by Representative Christopher Turner      

INSURANCE/HEALTH:  Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (RE1 NO IMPACT See Note)

Current Status:  Pending Legislative Bureau


Skip Navigation Links
TextExpand Text
AmendmentsExpand Amendments
DigestsExpand Digests
NotesExpand Notes
VotesExpand Votes
AuthorsExpand Authors

 Date   ChamberJournal
Page
Action sort history by ascending dates
05/07 S    Committee amendments read and adopted. Read by title and referred to the Legislative Bureau. Senate 5/7 Video  
05/06 S    Reported with amendments. Senate 5/6 Video  
04/15 S 9   Read second time by title and referred to the Committee on Insurance. INS 5/6 Video
Senate 4/15 Video  
04/14 S    Received in the Senate. Read first time by title and placed on the Calendar for a second reading. Senate 4/14 Video  
04/13 H 48   Read third time by title, amended, roll called on final passage, yeas 96, nays 0. Finally passed, title adopted, ordered to the Senate. House 4/13 Video  
04/13 H 47   Called from the calendar. House 4/13 Video  
04/09 H    Scheduled for floor debate on 04/13/2026.   
04/09 H 35   Notice given. House 4/9 Video  
04/09 H 35   Read by title, returned to the calendar. House 4/9 Video  
04/08 H    Scheduled for floor debate on 04/09/2026.   
04/07 H 16   Read by title, amended, ordered engrossed, passed to 3rd reading. House 4/7 Video  
04/01 H 69   Reported with amendments (10-0). House 4/1 Video  
03/09 H 105   Read by title, under the rules, referred to the Committee on Insurance. INS 4/1 Video
House 3/9 Video  
02/27 H    First appeared in the Interim Calendar on 2/27/2026.   
02/27 H    Under the rules, provisionally referred to the Committee on Insurance.   
02/27 H    Prefiled.